Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Pfizer Holds Out Hope For C. Diff Vaccine Despite Clinical, Commercial Failures
Sanofi’s Candidate Failed, Merck’s Zinplava Never Gained Traction
Mar 01 2022
•
By
Mandy Jackson
C. diff is most common in older adults • Source: Alamy
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Clinical Trials
More from R&D